Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q06643 (non-Hodgkin's lymphoma)
 11,307 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Cell volumes of neoplastic lymphocytes collected from lymph nodes of 53 patients with non-Hodgkin's lymphoma were compared to lymphocytes from 18 patients with reactive hyperplasia. The mean cell volume (MCV) and the modal volume (MV) of neoplastic lymphocytes were larger than the MCV and MV of lymphocytes from reactive hyperplasia. The cell volumes of neoplastic lymphocytes from patients with non-Hodgkin's lymphoma were more heterogeneous within and among cases than observed in volumes from lymphocytes of patients with reactive hyperplasia. The cell volumes of neoplastic lymphocytes corresponded to subgroups within the Rappaport Classification and the Working Formulation. Cell volumes of neoplastic cells from low-grade lymphomas were smaller than intermediate grade lymphomas which in turn were smaller than high-grade lymphomas. When cases of NHL were placed into three subtypes based on the MCV, large cell lymphomas had a significantly shorter survival then small and intermediate cell lymphomas at 12 months. However, a stepwise multiple regression analysis failed to demonstrate any independent value of cell volume in the prediction of survival.
 ...
PMID:Prognostic significance of mean cell volume in non-Hodgkin's lymphomas. 369 36

In 37 patients with seemingly localized non-Hodgkin's lymphoma of the Waldeyer's ring (WR-NHL), lymphangiography (LAG) and/or gallium-67 scans (Ga-67 scans) were done. Before these procedures, 20 patients were diagnosed as Stage I, and 17 as Stage II. LAG was done for 30, and Ga-67 scans for 32, 25 of whom had both. Five patients (16%) were upstaged to Stage III or IV by Ga-67 scans. Only one (3%) had abnormal LAG findings, in whom Ga-67 scans also showed abnormal accumulation in the para-aortic region. Because of this low positive rate, LAG is not recommended for staging of WR-NHL.
 ...
PMID:Value of gallium scans and lymphangiography in non-Hodgkin's lymphoma of the Waldeyer's ring. 377 11

Three hundred eighty-eight medical records of patients with lymphoma seen between 1971 and 1980 were analyzed for factors related to infection-associated mortality. Infection occurred in 100 patients (36 Hodgkin's lymphoma [HL], and 64 non-Hodgkin's lymphoma [NHL]). The overall mortality with infection was 17% (6 of 36) for HL and 52% (33 of 64) for NHL. In patients with NHL mortality correlated with infection in the respiratory tract (P less than or equal to 0.0001), blood (P less than or equal to 0.003), and multiple sites (P less than or equal to 0.0004) and with the following factors: granulocytopenia (P less than or equal to 0.05), thrombocytopenia (P less than or equal to 0.035), and cytotoxic therapy (P less than or equal to 0.034). Patients with HL showed a positive correlation only with staphylococcal infections (P less than or equal to 0.001) and monocytopenia (P less than or equal to 0.01). The above data may be used to generate a risk factor profile of patients at greater risk of mortality associated with such infections. Advance knowledge of such a profile may assist in the clinical management of these high-risk patients.
 ...
PMID:Mortality-associated factors in infected lymphoma patients. 382 63

A series of 20 patients with extra-nodal non-Hodgkin's lymphoma (ENHL) of the oral cavity was analysed with the emphasis on histopathological variability and prognostic factors. The current diagnostic schemes as devised for nodal NHL proved also to be useful in diagnosing ENHL in the oral cavity. With respect to histopathology, intra-oral ENHL differs from nodal NHL in a lower incidence of nodular growth pattern and a relative predominance of the lymphoma sub-type with large vesicular indented nuclei. These are features, however, that are shared with ENHL in other body sites and thus are not unique to the oral location. Another salient histological feature was the presence of proliferating bizarre spindle cells with formation of whorling bundles of reticulin, thus creating a pseudosarcomatous growth pattern in some cases. The clinical stage proved to be the main discriminating factor between those who survived and those who died of their lymphoma. Of the patients who were in stage IE on admission, 70% survived as opposed to only 20% of those who were in stage II or IV. A better prognosis for cases with soft tissue involvement as opposed to intraosseous lymphoma is probably due to a consistently lower clinical stage in the former group. The prognostic value of the clinical stage emphasizes the importance of adequate clinical staging procedures.
 ...
PMID:Extranodal non-Hodgkin's lymphoma of the oral tissues. An analysis of 20 cases. 385

Ultrastructural studies of normal and neoplastic lymphocytes are presented that qualitatively and quantitatively assess the central cell organelle currently used by surgical pathologists in the classification of non-Hodgkin's lymphoma, the nucleus. Events occurring during normal lymphocyte transformation can be used to appreciate essential mechanisms involved in producing the appearance of the nucleus as seen by microscopy. Quantitation of nuclear subcompartments by morphometric image analysis reveals that determination of nuclear size is primarily due to the ribonucleoprotein materials distributed between condensed chromatin masses, the interchromatinic (euchromatin or nuclear matrix) region. Furthermore, such investigations show that amounts and distribution of condensed chromatin in lymphocyte nuclei cannot be adequately assessed from routine histologic sections. Ultrastructural morphometric analysis of representative cases of the principal subtypes of NHL indicates that the atypical morphologic appearance of neoplastic lymphocytes results from a complex interplay between total amounts of condensed chromatin in nuclei and the size of individual aggregates of condensed chromatin, one or both of which may be abnormal in NHL. Abnormalities of interchromatinic materials are also likely involved in ordering the gross appearance of the nucleus. Understanding of both the dynamic capabilities of the nucleus, and the organization of and interplay between the various subcompartments of this organelle will be helpful in improving the classification of NHL by surgical pathologists.
 ...
PMID:Electron microscopic analysis of lymphocyte nuclei in non-Hodgkin's lymphoma. 391 28

Urinary tract involvement by non-Hodgkin's lymphoma is uncommon and whilst extranodal disease may be the first manifestation of NHL in 15% of patients, the primary site of origin of NHL in the urinary tract is very rare. At the time of diagnosis, apparently primary urogenital lymphoma is often widely disseminated, with a correspondingly poor prognosis.
 ...
PMID:Urinary tract lymphoma. 394 54

From 1969 to 1982, 183 patients with previously untreated stages IIIB and IV Hodgkin's disease and relapsing Hodgkin's disease after radiation therapy were treated with combination chemotherapy plus low-dose irradiation (CRT). One hundred fifty patients who achieved a complete response (CR) were analyzed for risk of developing a second neoplasm. Median follow-up has been 8.3 years. Actuarial survival of all patients is 74% at 10 years with a relapse-free survival of 68%. An additional 24 patients with stage IIIA disease were also treated with CRT. There were 22 CRs at risk who were analyzed. Median follow-up has been 3+ years with an actuarial survival of 90% at five years and a relapse-free survival of 83%. Second neoplasms have developed in 14 of 172 patients at risk: acute nonlymphocytic leukemia (ANLL; five patients); aggressive histology non-Hodgkin's lymphoma (NHL; three patients); and a variety of solid neoplasms (six patients). Time to second neoplasm diagnosis after initial treatment ranged from 12 to 141 months. Five patients were older than 40 years. At the time of diagnosis of the second malignancy, 11 patients were free of Hodgkin's disease (for 36 to 141 months) and three were receiving therapy for recurrent Hodgkin's disease. The 10-year actuarial risk (%) of developing ANLL was 5.9 +/- 2.8; for NHL, the risk was 3.5 +/- 2.4, and for solid neoplasms, 5.8 +/- 3.0. Our results suggest that combination chemotherapy plus low-dose irradiation does not appear to significantly increase the risk of developing second neoplasms above that already reported for combination chemotherapy when administered as either initial or salvage treatment of Hodgkin's disease.
 ...
PMID:Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience. 395 Jun 74

Twenty-nine cases of non-Hodgkin's lymphoma of Waldeyer's ring (W-NHL) and nasal cavity or paranasal sinus (N-NHL) were studied for tumor-surface marker phenotype and histopathologic correlation with clinical features. Immunostaining procedures on tissue sections by using xenoantisera and monoclonal antibodies to human B- and T-cells enabled the authors to demonstrate precise surface marker phenotypes of tumor cells and, moreover, the histologic localization of normal or neoplastic B- and T-cells in preserving the original structure of lymphoid organs or tumor tissues. In 22 cases of W-NHL, 19 (86%) had B-cell markers and 3 (14%) had T-cell markers, whereas 6 of 7 cases (86%) of N-NHL had T-cell markers. Tumor cells in T-cell lymphomas in W-NHL and N-NHL reacted with antibodies to peripheral T-cells except one case of W-NHL. Rappaport "histiocytic" subtype was heterogeneous with respect to both surface marker characteristics and morphologic features, i.e., seven had B-cell markers and four had T-cell markers, and they were all subdivided into "large cell" or "large cell, immunoblastic" in Working Formulation and "large cell" or "pleomorphic" in Lymphoma Study Group classification. The actuarial survival curve for all T-cell lymphoma patients was characterized by a rapid initial decline and a subsequent plateau, which contained two of the long survivors. In contrast, the B-cell lymphoma group had a more graded decline. The median and actuarial survivals of the T-cell lymphoma group were far inferior to those for the lymphoma group that expressed B-cell markers.
 ...
PMID:Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. 401 70

The following data have been achieved in investigation of 40 patients with non-Hodgkin's lymphoma involvement of the Waldeyer's ring (WR): a) Palatinal tonsils and nasopharynx are the parts of WR most frequently involved. b) Involvement of WR warrants a careful X-ray, and/or endoscopic examination of the gastrointestinal tract. c) WR is most frequently involved in patients with diffuse histiocytic and lymphohistiocytic NHL. d) The basic treatment in patients of clinical Stage I and II is local-regional radiotherapy, in those of Stage III and IV, it is combined chemotherapy. Of key importance in the choice of the strategy and tactics of treatment is the determination of histological subgroup. e) Prognosis in patients with NHL probably does not depend on the origin of the disease but rather on basic stratification criteria (clinical stage, histological subgroup, occurrence or absence of systemic symptoms, presence or absence of bulky tumors). The results are significantly influenced by the degree of radicality of treatment. Methods of a "local-regional" treatment appear to be inadequate in the majority of patients with NHL of high and intermediate grade malignancy. Consequently, the involvement of WR does not seem to represent a distinct clinical-pathological entity.
 ...
PMID:Non-Hodgkin's lymphomas of Waldeyer's ring. 408 92

The labelling index (LI) of untreated B cell non-Hodgkin's lymphoma (B NHL) in children was significantly higher (P less than 0.002) than the LI of untreated T cell malignancies (median LI 27.7% and 10.3%, respectively). In B NHL abdominal tumour material showed a significantly higher in vitro incorporation of tritiated thymidine (3H-dT) than extra-abdominal tumour material (P less than 0.01). Sequential immunological, cytochemical and cytokinetic studies revealed tumour cells in up to three marker-defined subpopulations of lymphoid cells. In all 14 patients examined the LI of E-Ia+sIgM+ cells was higher than the LI of E+Ia+/-sIgM- cells; in all eight patients with Ia+ and Ia- tumour cells the former had a higher LI than the latter (P less than 0.002). In all T cell neoplasia (T ALL/NHL) investigated malignant cells were found in two of the three marker-defined subsets of lymphoid cells. In 10/13 patients the E-rosette positive blast cells had a higher LI than the E-rosette negative T blast cells. For the small group of patients with T cell malignancies no significant difference in the overall LI between OKT9+ stage I (early thymocyte) and OKT9- stage II (cortical thymocyte) neoplasias could be found. However, within the malignant clone of a T cell malignancy the expression of the OKT9 (transferrin receptor) but not the cortical thymocyte (HTA-1) antigen was related to the in vitro 3H-dT incorporation.
 ...
PMID:Differentiation and cytokinetic analyses of normal and neoplastic lymphoid cells in B and T cell malignancies of childhood. 633 42


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>